LAG3 and neoplasm: LAG3 positive tumours with tumour stages > pT2 had a median OS of 70.2 months (95% CI 20.6–32.0 months), while LAG3 negative tumours with tumour stages > pT2 showed a median OS of 25.0 months (95% CI 2.1–154.6 months) (p = 0.037).